Brief: Vor Biopharma Files For 1-For-20 Reverse Stock Split - SEC Filing
17/09/2025 14:07
Sept 17 (Reuters) - Vor Biopharma Inc VOR.O: VOR BIOPHARMA INC - FILES FOR 1-FOR-20 REVERSE STOCK SPLIT - SEC FILING Source text: [ID:n0001193125-25-205553] Further company coverage: VOR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vor Biopharma
See all newsBrief: Telitacicept Demonstrates Durable Preservation Of Kidney Function Through Two Years In Phase 3 Teligan Trial In Iga Nephropathy
Vor Bio says its experimental drug slowed loss of kidney function in late-stage study
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
U.S. STOCKS ON THE MOVE-Snowflake, Cboe, Oracle
US STOCKS ON THE MOVE-Veracyte, Staar Surgical, Corning